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ABSTRACT

A major limitation of using synthetic scaffolds in tissue engineering is little
growth of incorporated cells in the interior of the scaffold, resulting in insufficient
angiogenesis in the scaffold interior. Recently, cells have been 3D bioprinted
concurrently with biomaterials to produce a cellularized, bioactive, angiogenic 3D
environment. This thesis describes a novel solvent-extrusion method for printing
polycaprolactone (PCL)/bioactive borate glass composite as a biomaterial for a cell-laden
scaffold.
Bioactive borate glass was added to a mixture of PCL and organic solvent to
make an extrudable paste, creating scaffolds measuring 10×10×1 mm3 in overall
dimensions with pore sizes ranging from 100–300 μm. We compared depositing hydrogel
droplets to depositing hydrogel filaments in between the PCL/borate glass composite
filaments. Degradation of the composite scaffold with and without the presence of
hydrogel was investigated by soaking the scaffold in cell culture medium. The weight
loss of the scaffold together with formation of a hydroxyapatite-like layer on the surface
shows the excellent bioactivity of the scaffold. This work demonstrates that incorporating
borate glass to increase the angiogenic capacity of the fabricated scaffolds is feasible. We
also compared cell survival and viability between the composite bio-ink to two
commonly used hydrogels, Matrigel and Pluronic F127. The viability and proliferation of
cells in the different biomaterials were analyzed with different methods demonstrating
that cell viability was similar between the different bio-inks. This 3D bioprinting method
shows a high potential to create a bioactive, highly angiogenic 3D environment required
for complex and dynamic interactions that govern the cell’s behavior in vivo.
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1. INTRODUCTION

Bone defects, resulting from trauma, cancer, arthritis, infection, or congenital
skeletal abnormalities, account for approximately 34 million surgeries per year.1 While
autologous bone grafts achieve the best result, they create new defects and the possibility
of increased morbidity in donors.2–6 Allografts can circumvent these issues, but they are
troubled with limited availability, concerns over immunogenicity, and potential disease
transmission.7 Engineered bone scaffolds are another treatment option but have not been
as successful as autologous grafts due to insufficient vascularization and poor
biomechanical function.8–10
Additive manufacturing, also known as 3D bioprinting, is of particular interest in
orthopedics due to the ability to print scaffolds with complex designs, controlled
chemistry, and interconnected pores. 3D bioprinting is a process that fabricates a “living”
construct in a layer-by-layer fashion using a “bio-ink” (cells suspended in a medium)
with or without additional materials. The creation of a 3D environment with spatial
arrangement of cells and materials is essential for vascularization and, therefore,
complete implant integration with the surrounding tissue.
3D bioprinting techniques can be broadly classified into four categories: (i) laserassisted,11,12 (ii) inkjet-based,13 (iii) stereolithography,10 and (iv) extrusion-based
printing.14 In laser-assisted printing, energy generated by a laser pulse is used indirectly
to create a droplet from a cell containing ribbon that is then deposited on a substrate.8,9
The advantage of this process is being able to print relatively high viscosity biological
materials with suspended cells. However, process precision and material properties
required for shape control limits the availability of materials for this system. Inkjet
printing produces fine droplets of cells suspended in media that can be deposited at high
resolutions (~20 µm). However, the process can only utilize low-viscosity materials.6,7
Stereolithography is a well-known and established technique in the 3D printing industry
and works on the principle of selective photopolymerization using a light energy source
on a reservoir containing materials and cells with a photo initiator. The resolution of the
process depends on the laser spot-size which is generally high but is limited to using only
photopolymerizable materials.10
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The last category of bioprinting, extrusion-based 3D bioprinting, allows the
printing of cells, hydrogels, and other materials using one or multiple syringes and a
pressure system. The pressure system consists of either a mechanical piston or a
pneumatic pressure source (mostly compressed air) that is computer controlled. The
material is extruded through a nozzle tip (industry standard) with orifice ranging from
less than 100 µm to several hundred microns in diameter. The main advantage of
extrusion based bioprinting is the wide range of materials that are compatible with the
process, including high viscosity biopolymer pastes and hydrogels. The process can
deposit hydrogels with different gelation mechanisms, with high cell density, and with
minimal waste in comparison to laser assisted and stereolithography techniques. Overall,
extrusion-based bioprinting is a very promising biofabrication method.15,16
Synthetic materials, such as polycaprolactone (PCL), provide strength and
elasticity to scaffolds. In addition, due to the high temperature required to melt other
biopolymers such as polylactic acid (PLA, with a melting point of 160oC), PCL has
become one of the most widely used biocompatible polymers owing to its low melting
point of 60oC.17,18 For 3D printing, PCL is an attractive option because of its good
rheological and viscoelastic properties. Despite its slow degradation rate (~2 years
depending on the molecular weight), PCL has been widely used to fabricate scaffolds for
bone tissue engineering.18–20
Because pure polymer scaffolds fabricated using the melt-deposition process are
only biocompatible and do not react in the body, another challenge is to make the
scaffold bioactive. Bioactive glasses are biocompatible and resorbable, can be made into
custom compositions and geometries, can be tailored to reliably degrade in minutes to
years, and can be doped with most elements (i.e. copper).12 Additionally, most bioactive
glasses form a hydroxyapatite (HA)-like layer, which is the precursor to bone, that bonds
with both hard and soft tissue.9 Recently, silicate bioglasses – such as 45S5 – have been
shown to be non-toxic to stem cells, serve as an excellent delivery vehicle for angiogenic
factors and cells, and can contribute to stem cell differentiation into an osteogenic
lineage.21,22 However, less is known about the effect of borate based bioglass 12-93B3.
13-93B3 bioglass has a higher reaction rate (5-10 times faster than silicate glasses); is
more resorbable (60 to 70% wt. loss) in a few days to weeks; and is angiogenic,
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antimicrobial, and osteo stimulatory/conductive (Table 1.1).23–25 Despite these promising
attributes, the use of borate based bioglass is limited due to the low strength and
brittleness of glass in porous scaffolds required for bone repair.

Table 1.1 Composition of 45S5 and 13-93B3 bioactive glasses.14
Glass

SiO2

B2O3

Na2O

K2O

MgO

CaO

P2O5

In vivo Reaction
rate (µm/wk)

45S5

45.0

0

24.5

0

0

24.5

6.0

~5-6

13-93B3

0

53.0

6.0

12.0

5.0

20.0

4.0

~30-45

Composite scaffolds can combine the benefits of multiple materials. By
increasing the complexity of the scaffold with multiple materials and cells, matching both
the biomechanical and biological properties of the target tissue becomes more
feasible.15,16 In the past, researchers made polymer-bioactive glass scaffolds using fused
deposition modeling (FDM).26 In FDM, the polymer is melted and deposited as filaments
that solidify upon cooling in a layer-by-layer fashion. However, no significant
improvement in bioactivity and cell growth was reported, which could be due to the
inadequate ionic dissolution of the glass into the surrounding environment. This makes
melt-deposition options unattractive for fabrication of polymer-glass composite scaffolds
as they are less reactive when combined with bioactive materials. Therefore, it is
essential to investigate alternate approaches for printing materials, such as solvent-based
fabrication methods.
A variety of solvents are available to dissolve different biopolymers.27 Extrusion
of solvent dissolved polymer and bioactive glass is safe at room temperature and reduces
the process complexity since there is no need for temperature control. This method can be
adopted by most of the existing open-source 3D printers available in the market. Previous
studies have used chloroform (CF) to dissolve PCL for biomaterial applications.28 As a
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solvent, CF provides: (i) a high viscosity paste, making it suitable for extrusion-based 3D
printing, (ii) fast evaporation (~2 min), making it safe to print cells during the fabrication
process, (iii) filament porosity for accelerated glass dissolution to the surrounding, and
(iv) faster polymer bulk degradation by exposing the interior of filament.
Another requirement to fabricate a “living” construct is cells. Mesenchymal stem /
progenitor cells (MSCs) have been used for cell therapy and in tissue engineering
because of their ability to differentiate into multiple mesenchymal lineages in vitro,
immune modulatory effects, and angiogenic capacity.29,30 MSCs have been isolated from
several tissues, including the bone marrow (BMSCs), adipose tissue (ASCs), and skin
tissue.31–34 The frequency of MSCs in adipose tissue is much higher than the more
commonly studied source of bone marrow, yielding 100 to 500 times more cells per
tissue volume.35,36 ASCs have similar self-renewal abilities, common surface epitopes,
growth kinetics, and cytokine expression profiles to BMSCs. ASCs are isolated from the
stromal vascular fractions (SVF) of subcutaneous white adipose tissue. A heterogenous
cell population, SVF also includes blood cells, endothelial cells, adipocytes,
macrophages, and various growth factors.37–40
In this series of studies, we (i) developed a novel composite scaffold wherein a
polymer is dissolved in chloroform, mixed with borate bioactive glass, and then extruded
to fabricate the scaffold, (ii) used this novel composite as a bio-ink for stem cells and
compared cell survival to other commonly used bio-inks, (iii) compared different sources
of stem cell populations from different species as bio-printing candidates, (iv)
investigated the best scientific method to analyze stem cell activity after printing cells in
different bio-inks.
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2. MATERIALS AND METHODS

2.1. CELL CULTURE
2.1.1. Isolation of Rat Stromal Vascular Fraction. Subcutaneous white
adipose tissue was collected from 6-13 week old Sprague Dawley rats weighing 180-250
grams. Approximately 3.5 grams of adipose tissue was collected per rat. Adipose tissue
was washed in 50 mL of Hanks’ balanced salt solution (HBSS, Lonza, Walkersville, MD,
USA) 2-3 times until the medium remained clear when shaken vigorously. To isolate the
stromal vascular fraction (SVF), adipose tissue was minced with a razorblade and then
incubated in a 0.1% (w/v) collagenase (from Clostridium histolyticum, Sigma-Aldrich,
St. Louis, MO) HBSS solution in a 50 mL centrifuge tube at 37oC on a 5x G shaker
(Innova 4000, New Brunswick Scientific, Edison, NJ) for approximately 3 hours. During
incubation, tissue was additionally shaken manually and vigorously for 5-10 seconds
every 15 minutes.
After forming a “soup like” consistency, the collagenase was neutralized by
adding an equal volume of D-10 cell culture media that consisted of 10% fetal bovine
serum (FBS, Corning, Manassas, Virginia, USA), 1% 100x L-glutamine (GE Life
Sciences, Logan, UT), 2% 100x antibiotic/antimycotic (GE Life Sciences, Logan, UT)
and Dubelcco’s minimum essential media (DMEM, Sigma-Aldrich, St. Louis, MO).
Digested tissue was filtered through a 100 μm mesh filter followed by a 70 μm mesh
filter. The filtered cell solution was centrifuged at room temperature at 1000x g for 10
minutes. The supernatant was aspirated, leaving the SVF pellet.
2.1.2. Isolation of Rat Bone Marrow Derived Mesenchymal Stem Cells.
Femurs were collected from 6-13 week old Sprague Dawley rats averaging 180-250
grams. Within one hour of being sacrificed with carbon dioxide, femurs were removed,
both distal ends of the femur were cut, and an 18 gauge needle was inserted into the shaft.
Approximately 5 mLs of D-10 media was expelled into the femur to flush cells into a 25
cm2 culture flask (TPP, Trasadingen, Switzerland). Flushing was repeated 3-5 times.
After cells incubated overnight at 37oC with 5% CO2, they were then washed three times
with 2 mL of pre-warmed phosphate buffered saline (PBS; Lonzo, Walkersville, MD). D-
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10 media was replaced every 3-4 days. When cells became 65-75% confluent, flasks
were washed three times with 2 mL of pre-warmed PBS, harvested with 0.25% trypsin/
1mM EDTA, and passaged at 100 cells/ cm2. Passage 2-4 was used for all experiments.
2.1.3. Cell Culture of Human Mesenchymal Stem Cells. Frozen vials of
approximately 1x106 human ASCs (hASCs; LaCell, New Orleans, LA) or human BMSCs
(hBMSCs; Texas A&M Institute for Regenerative Medicine, Temple, TX) were obtained
from separate donors (Table 2.1). Vials were quickly unthawed in a water bath, plated on
150 cm2 culture dishes in 25 mL complete culture media (CCM), and incubated at 37oC
with 5% CO2 overnight. CCM contained 10% fetal bovine serum, 1% 100x L-glutamine,
2% 100x antibiotic/antimycotic, and minimum essential medium alpha modified (αMEM, Sigma-Aldrich, St. Louis, MO). Cells were washed three times with 4 mL of prewarmed PBS, harvested with 0.25% trypsin/ 1mM EDTA, and passaged at 100 cells/cm2
in CCM. Media was changed every 3 to 4 days. For all experiments, sub-confluent cells
(≤70% confluent) between passages 2 and 6 were used.

Table 2.1 Demographic information for human MSCs.
Cell Type

Race

Age

hASC-1

Caucasian 40

F

24.37

hASC-2

Caucasian 49

F

27.34

hASC-3

Caucasion 28

F

24.65

hBMSC-1

N/A

M

N/A

28

Gender BMI

2.2. PREPARATION OF BIO-INKS
2.2.1. PCL/13-93B3 Composite. Polycaprolactone (Sigma- Aldrich, St.
St. Louis, MO) was dissolved in chloroform (CF; Sigma-Aldrich, St. Louis, MO) in a
covered glass container with the help of a stirrer at ~45°C. The PCL weight to CF volume
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ratio (grams:mL) was varied from 1:1 to 5:4 to determine the ideal ratio for printing. An
appropriate ratio was established by visually inspecting the paste and through filament
extrusion using a digital syringe dispenser (Loctite®, Henkel North America, Rocky Hill,
CT). Then, 13-93B3 glass (Mo-Sci Corporation, Rolla, MO) with ~20 µm particle size
was added to the PCL:CF mix in five different weight percentages in increments of 10%
ranging from 10% to 50%. A magnetic stir bar was used to uniformly mix the composite
paste, and no settling of the glass particle precipitate was observed before transferring the
paste to a syringe. Each ratio was tested using a digital syringe dispenser at air pressure
ranging from 10 to 50 psi and with nozzle tip diameter ranging from 110 to 600 µm.
2.2.2. Matrigel. Matrigel (Corning, Bedford, MA) was thawed on ice for 3
hours and diluted in DMEM to 9 mg/mL for droplets or to 4.5 mg/mL for filaments. For
droplets, hASCs were suspended at a concentration of 10x106/mL of Matrigel. For
filaments, 5x106 rBMSCs/mL or 5x106 rSVF/mL of Matrigel was used. Matrigel was
gently mixed to obtain a uniform distribution of cells and transferred to a 160 µm nozzle
tip. Matrigel incubated at 37oC for 5 minutes to crosslink before printing.
2.2.3. Pluronic F-127 Hydrogel. Pluronic F-127 hyrdogel (Pluronic; SigmaAldrich, St. Louis, MO) of 15% or 25% (w/v) was prepared using DMEM in a 50 mL
glass beaker placed in an ice bath. The solution was mixed, covered, using a magnetic stir
bar until Pluronic dissolved (about 30 minutes). The solution was allowed to sit for an
hour at 4oC to remove bubbles formed during stirring. For filaments, 5x106 rBMSCs/mL
or 5x106 rSVF/mL of Pluronic was used. Pluronic was gently mixed to obtain a uniform
distribution of cells and transferred to a 160 µm nozzle tip. The Pluronic incubated at
37oC for 5 minutes to crosslink before printing.

2.3. SCAFFOLD FABRICATION
Scaffolds (10x10 mm2) were printed with 0-90o orientation of the filaments in alternate
layers. Printing was performed with an assembled DIY 3D printer (Geeetech, Prusa I3 A
Pro) that was modified to have two syringes connected to digital dispensers that were
computer controlled (Figure 2.1). Scaffolds were printed either on a microscope slide
(Thermo Fischer Scientific, Rochester, NY) or in a 12-well tissue culture plate (TPP,
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Trasadingen, Switzerland). The printing parameters such as filament spacing, layer
height, printing speed, etc. were identified based on visual inspection and optical
microscopic images after a single layer extrusion. Printing parameters such as needle tip
sizes and printing speed were uniform for all paste compositions after initial trials.
Parameters such as air pressure and filament overlap were correspondingly modified for
different pastes (Table 3.1).

Figure 2.1 Schematic of (A) printer design and (B) set-up.

2.4. SCAFFOLD DEGRADATION
Degradation of the PCL/13-93B3 composite was evaluated on 10x10x1 mm3
scaffolds. Scaffolds were weighed and then placed in high density polyethylene (HDPE)
bottles containing 300 mL of α-MEM per 1 g of scaffold for soaking, and incubated at
37oC from 1-14 days. After incubation, scaffolds were removed, gently washed with 2
mL of room temperature deionized (DI) water three times, and dried overnight. The dried
scaffold was weighed to calculate the weight loss percentage. Each time interval had an
n=3 and results were reported as mean ± standard deviation using a student t-test.
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2.5. SCAFFOLD CHARACTERIZATION
Microscopic images were used to measure the filament width and pore size of the
PCL/13-93B3 composite. Once fully dried, samples of the scaffold both just after printing
and after the degradation study were sputter coated with gold/palladium (Au/Pd) for 60
seconds. Scanning electron microscopy (SEM, Hitachi S-4700 FESEM, Hitachi Co.,
Tokyo, Japan) images were taken to evaluate the surface morphology of the scaffolds,
internal structure of the filaments, and formation of hydroxyapatite-like material on the
scaffold surface. Scans were run from 2θ values ranging from 10o to 80o using Cu Kα
radiation (λ = 0.154056 nm) for X-ray diffraction (XRD) analysis (Philips X-Pert,
Westborough, MA) on the as-received PCL, as-printed PCL/B3 glass scaffold, and the
scaffold after α-MEM immersion to determine the changes in the crystalline/amorphous
nature of the material. At least five measurements were taken of each scaffold; results
were reported as mean ± standard deviation

2.6. LIVE/DEAD ASSAY
Printed cell-laded scaffolds incubated for 1 or 7 days in D-10 at 37oC with 5%
CO2. Cell numbers and viability was evaluated by a live/dead assay, per manufacturer’s
protocol (Life Technologies, Eugene, OR). In brief, scaffolds were removed from the
incubator, washed three times in pre-warmed PBS, and incubated in live/dead stain for 15
minutes at room temp. Five images per scaffold were taken on a fluorescent microscope
(Olympus IX51, Melville, NY), and images were quantified using Fiji software (NIH,
Betheseda, MD). Each time point had an n=3 and results were reported as mean ±
standard deviation using a student t-test

2.7. DNA QUANTIFICATION
Printed cell-laded scaffolds incubated for 1 or 7 days in D-10 at 37oC with 5%
CO2. DNA was quantified with CyQuant, per manufacturer’s protocol (Life
Technologies, Eugene, OR). In brief, scaffolds were removed from the incubator,
washed three times in pre-warmed PBS, lifted with 0.25% trypsin/1mM EDTA, pelleted
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in a 1.5 mL vial, and frozen at -80oC. The pellet was incubated with CyQuant at room
temperature for 5 minutes and fluorescence was measured at a wavelength of 480 nm
using a microplate reader (FLUOstar Omega, BMG Labtech, Offenburg, Germany). The
mean cell number ± standard deviation was calculated in excel with n=3 against a
standard with a curve fit of R=0.99 and graphed.

2.8. QUANTIFICATION OF CELL NUMBER
To determine the number of cells printed, droplets of bio-ink were printed on a
microscope slide and immediately fixed in 10% paraformaldehyde (PFA; Affymetrix,
Cleveland, OH). Droplets were stained with DAPI (Vector Laboratories, Burlingame,
CA) and examined using a fluorescent microscope. The entire area of each droplet (n=4)
was imaged and the approximate cell number was determined using Fiji software.

2.9. METABOLIC QUANTIFICATION
Printed cell-laded scaffolds incubated for 1 or 7 days in D-10 at 37oC with 5%
CO2. Scaffolds were then removed from the incubator, washed three times with PBS,
lifted with 0.25% trypsin/1mM EDTA, and pelleted in a 1.5 mL vial.
Cells were re-suspended in 100 μL of D-10, transferred to a 96-well culture plate
(TPP, Trasadingen, Switzerland) and cellular metabolic activity was measured with an
MTT assay (Trevigen, Gaithersburg, MD) performed according to manufacturer’s
protocol. Briefly, the MTT reagent was added, the plate incubated for 3 hours at 37oC,
detergent was added, and the plate was left covered at room temperature overnight.
Absorbance was measured at a wavelength of 570 nm using a microplate reader. Cell
viability was calculated with n=3 using Excel and the mean absorbance ± standard
deviation was graphed.
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3. RESULTS
3.1. FABRICATION OF NOVEL PCL/13-93B3 GLASS SCAFFOLD
3.1.1. Single Layer Tests. The weight percentage of PCL was varied from
1:1 to 5:4 (in grams of PCL to mL of chloroform) to determine the best ratio for
fabricating the scaffold. During the initial set of tests, different compositions of paste
were extruded using a hand-held syringe and with the help of a digital dispenser while
varying the nozzle tip size and the air pressure. An air pressure between 30 and 50 psi
provided uniform extrusion of the PCL+chloroform mixture. The ideal ratio of PCL and
chloroform was determined to be 5 g of PCL to 3 mL of chloroform, extruded at 30 psi
using a 260 µm (25G) nozzle tip. A larger tip size (>260 µm) would result in thick
filaments which were not beneficial for achieving small pore size distribution in the
scaffold. From there, 10 wt.% 13-93B3 glass was mixed with the PCL and chloroform
and extruded using the printer from 3 to 10 mm/s. A reduced filament width (from 0.8
mm to 1.8 mm) can be observed with increasing printing speed (Figure 3.1). The width of
the filament also depended on the homogeneity of the mixture.

Figure 3.1 Single layer tests with C1 composite using different printing speeds (A)
3mm/s, (B) 5mm/s, and (C) 10 mm/s.
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3.1.2. Two Layer Tests. The filament height and the spacing of the first layer
were crucial parameters when printing successive layers. The filament height determined
the height for each layer while the filament spacing defines how well the filaments bridge
across the previous layer. The average height of filaments printed using a speed of 8
mm/s was ~75 µm (Figure 3.2A). Therefore, a distance of 100 µm between the nozzle tip
and substrate or previously deposited layer was used to fabricate subsequent scaffolds.
The height of the filaments for 40 wt% and 50 wt% glass compositions remained the
same if the same nozzle tip was used. The roundness of the filament improved with a
smaller tip but because of the nozzle clogging issues, all the experiments were carried out
with a 260 µm tip. Another important factor in this study is the dwell time between
consecutive layers as this allows the chloroform to evaporate and allow the bottom layer
to become more solid. A longer dwell time (>5 min) would warp the layer and a shorter
dwell time (<1 min) is not sufficient for the layer to dry. The difficulty in bridging the
second layer without dwell time can be noticed and was substantially improved with 1
mm dwell time (Figure 3.2C). The ideal dwell time between layers was determined to be
2-3 minutes (Figure 3.2D).

Figure 3.2 Determining layer height and dwell time on 10x10 mm2 scaffolds.
(A) Cross-sectional view of the C3 filament measuring ~75 µm in height, (B) Second
layer printing with zero dwell time, (C) Second layer printing with 1 min dwell time, and
(D) Second layer printed with 2.5 min dwell time
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3.1.3. Multiple Layer Scaffolds. Based on the previous tests, scaffolds with
multiple layers were fabricated using all five compositions (i.e. 10 wt.% to 50 wt.% 1393B3 glass). The minimum air pressure required to extrude the paste increased when
glass content was increased from 10 wt.% to 30 wt.%. At higher glass content (40 wt.%
and 50 wt.%), the nozzle clogged during fabrication. Therefore, additional chloroform
(about 1 mL) was added to the paste to reduce the viscosity for clog-free extrusion using
the 260 µm tip. The 13-93B3 glass weight percentage and PCL:Chloroform ratios used to
make composite pastes are shown in Table 3.1.

Table 3.1 PCL/13-93B3 paste compositions and printing parameters.
Composite
Paste #
C1

13-93B3
Glass
(Wt. %)
10

Air
Filament PCL:CF Final Printing Parameters
Pressure Spacing (g to mL) (using C5 paste)
(psi)
(µm)
30
600-800
5:3
Printing speed – 8 mm/s

C2

20

30

600-800

5:3

Dwell time – 2 min

C3

30

40

600-800

5:3

Nozzle distance – 100 µm

C4

40

30

700-800

5:4

Air pressure – 30 psi

C5

50

30

700-800

5:4

Nozzle tip – 260 µm

A filament width of 397±10 μm was measured for scaffolds printed with the C5
paste while average pore size is dependent on the filament spacing. A filament spacing of
600 µm provided square pores measuring ~160 µm (Figure 3.3A). In comparison, the
average pore size was ~350 µm for scaffolds with 800 µm filament spacing while in
scaffolds with a spacing 700 µm, the pore size varied from ~200 to ~300 μm. Therefore,
pore sizes could be adjusted by modifying the filament spacing, to a certain extent, to suit
a certain tissue engineering application of the fabricated scaffold.
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Figure 3.3 Micro- and macroscopic images of PCL/13-93B3 composite scaffolds.
(A) Optical microscopic image showing the pores (~160 µm) in a composite scaffold
fabricated with C5 paste. (B) Scaffolds fabricated with different composite pastes (C1 to
C5); warpage shown with an arrow indicating space between scaffold and slide. Warpage
was minimal in C3/C4 scaffolds and completely absent in C5 scaffolds. (C) Cross section
of C5 scaffold showing filaments unable to bridge filaments from previous layer.

It should be noted that the maximum thickness (or height) of the scaffolds
depends on the degree of chloroform evaporation and the distance between layers. All the
experiments were carried out at room temperature (64°F) where the variation in relative
humidity (58-60%) was not considered to be a major factor. Faster chloroform
evaporation would produce warpage of the fabricated scaffold, especially with some
dwell time between the layers. Non-uniform distribution of the PCL and glass is not
believed to be one of the major factors of warpage as, upon examination of the filaments’
microstructure when printed with the same syringe at different time intervals, there was
similar and uniform deposition of glass particles throughout the matrix. Therefore, the
chloroform evaporation and the percentage of PCL in the composite are two of the crucial
factors that determine the warpage. Increasing the glass content in the composite would
indirectly decrease the chloroform content and thereby aids in faster evaporation and
improves the filament rigidity. Warping was predominant with C1 and C2 pastes while
fabricating scaffolds using an 800 µm filament spacing and this led to difficulty in
printing after about 8 layers (640 µm) (Figure 3.3B). The warpage in scaffolds fabricated
with C3 paste was less pronounced and a scaffold height of 800 µm (10 layers) was
obtained. Overall, the best results were achieved for scaffolds fabricated with C5 paste as
they were successfully printed to 1 mm height (12 layers). The scaffolds fabricated with
C5 paste had enough strength to be safely handled for subsequent degradation and in
vitro assessment. The scaffolds fabricated with the C3-C5 pastes were reproducible to the
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extent that 3 out of 4 scaffolds were consistent in quality. However, even with the C5
paste, there was insufficient bridging between the filaments, resulting in a mesh with
pores only in one direction rather than a porous scaffold (Figure 3.3C).

3.2. MICROSCTRUCTURE EVALUATION OF PCL/13-93B3 COMPOSITE
SCAFFOLD
Scanning electron micrographs of composite scaffolds made with C4 and C5
composites showed the surface morphology of the filament (Figure 3.4). Glass particles
are conspicuously absent from the surface of the scaffold filaments (Figure 3.4A-C). No
pores on the filament surface were detected even when observed at a 2000x
magnification (Figure 3.4C). Glass particles dispersed in the PCL matrix can be seen in
the interior when examining the cross-sectional surface of the filament (Figure 3.4D-F).
The dissolved PCL in chloroform encloses the glass particles and surface tension effects
between the nozzle tip and PCL during extrusion appear to have caused the presence of
only PCL on the surface.

Figure 3.4 SEM images of the C5 PCL/13-93B3 glass scaffold.
(A) Low magnification (30x) and (B) Medium magnification (90x) images of scaffold
surface showing filaments and pores, (C) Smooth surface morphology of filament (2000x
magnified image), (D) Fractured surface of a broken filament with PCL matrix and glass
particles, (E-F) Magnified image of the fracture surface in (D).
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3.3. DEGRADATION AND BIOACTIVITY OF PCL/13-93B3 COMPOSITE
SCAFFOLD
The degradation of the composite was evaluated by soaking the scaffolds in αMEM for 1, 3, 7, and 14 days. The scaffold weight before and after immersion (post
drying) was recorded at each time interval. No significant weight loss was observed for 3
days (less than 1%), and the measured weight loss was 10.7±5% at 7 days and 23.2±4%
at 14 days. As PCL takes a longer time to degrade, the weight loss measured is most
likely due to the ionic dissolution of the 13-93B3 borate glass.
Formation of flower like florets, which typically represent HA-like material, was
observed on the filament surface (Figure 3.5A and 3.5B). Fine cracks on the filament
surface which are a couple of microns wide and up to ten microns or more in length can
be observed in Figure 3.5C.

Figure 3.5 SEM images of a C5 glass scaffold after 14 day immersion in α-MEM at 37oC.
(A) ~1 µm thick layer was formed on the filament surface (a piece of the reacted layer
indicated by arrow raised to expose the polymer beneath), (B) magnified image (8000x)
of the area marked in (A) showing the formation of HA-like florets on the filament. (C)
Surface cracks on the filament indicated by arrows in (i) and (ii). Pores inside the
filament measuring less than 10 µm are indicated by arrows in (iii).
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The degradation results also show a controlled release of 13-93B3 glass over a
period of two weeks into the surrounding solution (Figure 3.6). In the past, composite
thin films have been made using PCL/13-93B3 glass and PCL/45S5 glass with different
amount of glass content28. The degradation data of such thin films indicate that the entire
glass almost completely dissolves in about three days. The graph shown Figure 3.6
compares the weight loss percentage of the PCL/13-93B3 glass thin films (80 µm) with
that of the current study. Almost all the 13-93B3 glass was reacted in about 3 days from
thin films. The faster degradation in composite films could be due to the small thickness
of the film. The scaffolds in the current study are made by filaments which are about 400
µm in diameter and have no surface pores, which explains the very little glass dissolution
in three days. However, the water absorbing potential of polymers in general was
reportedly found to improve after the addition of bioceramic filler materials such as HA
and even bioactive glass19.

Figure 3.6 Weight loss comparison of 3D printed C5 scaffolds vs. thin film composites.28
The thickness of the scaffold filaments affects the degradation of the glass.
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In this study, the glass dissolution increased significantly after 7 and 14 days,
which is believed to be due to the internal porosity of the filament created after the CF
evaporation and glass dissolution creating more porosity. The B2O3 present in the borate
glass (Table 1.1) completely dissolves into the surrounding environment, and the
remaining oxides with the exception of MgO participate in the formation of HA. By
neglecting the weight of HA formed, it can be theoretically calculated that there is about
~35% weight loss for the scaffold, assuming a complete 13-93B3 glass dissolution in
50:50 PCL/13-93B3 composite. In this study, the weight loss for 50:50 PCL/13-93B3
composite scaffold was ~23%, indicating that ~70% of the 13-93B3 glass present in the
scaffold had reacted in 14 days. This degradation vs. time characteristic can be used to
develop a controlled degradation of 3D scaffold by adjusting the filament thickness that
is beneficial in certain tissue engineering applications, especially in drug delivery.
The energy-dispersive X-ray spectroscopy (EDX) analysis indicated the presence
of calcium (Ca), phosphorous (P), and oxygen (O) on the reacted surface of the scaffold
after 14-day immersion in α-MEM (Figure 3.7A) by detecting changes in elemental
composition in atomic weight percent along a line. The location of the scan was selected
such that a scan line (~70 µm long) had to start on a reacted surface, pass through the
exposed PCL surface, and end on the reacted surface (Figure 3.7B). All the signals from
the EDX analysis correspond to K series emissions (Kα and Kβ). It can be observed that
the percentage of Ca and P drops to zero along with a decrease in O when scanning the
PCL surface (from ~30 µm to ~50 µm in Figure 3.7A). The presence of Ca, P, and O
indicates that the glass has reacted and formed a material with a similar profile to HA on
the scaffold surface.
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Figure 3.7 EDX analysis on the surface of the C5 scaffold soaked in α-MEM.
(A) Graph of line scan data showing the variation in Ca, P, O, and C in atomic weight
percentages; presence of Ca, P, and O on the reacted surface confirms the glass
reaction and formation of HA-like material, (B) SEM image with the arrow line
indicating the scanned area for EDX analysis.

The reacted layer formed on the scaffold surface was ~1 µm thick and not
completely uniform (dense collection of florets can be seen in Figure 3.5B). XRD
analysis was performed to confirm the presence of crystalline HA but the XRD pattern
obtained on a 14 day soaked scaffold could not match the known HA crystalline peak.
This is believed to be due to the formation of amorphous HA or non-stoichiometric HA,
which is not uncommon in such cases. XRD patterns of the as-received 13-93B3 glass,
PCL/13-93B3 glass composite scaffold, and the composite scaffold after soaking in αMEM for 2 weeks were obtained (Figure 3.8). The semi-crystalline nature of the PCL
was confirmed with characteristic peaks (marked by *) and amorphous profile of 1393B3 glass with no sharp peaks and characteristic hump can be observed in the XRD
patterns (Figure 3.8). There are additional peaks observed for the α-MEM soaked sample
which could not be identified to a known material in the database (marked by †) that is
most likely non-stoichiometric HA. However, the typical amorphous hump seen in glass
was not existent in the soaked sample, indicating that most of the 13-93B3 glass in the
scaffold had reacted after 14 days.
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Figure 3.8 XRD patterns comparing different aspects of C5 scaffolds.
(A) 50:50 PCL/13-93B3 glass composite scaffold soaked in α-MEM for 14 days, (B)
PCL/13-93B3 glass scaffold as printed, (C) as-received PCL showing a semi-crystalline
nature with characteristic peaks marked by *, and (D) as-received 13-93B3 glass with
characteristic amorphous hump (25° to 35° and 40° to 50°).

3.4. COMPARISON WITH 45S5
Due to the mesh structure seen when using the 13-93B3 glass, a comparison was
made using the silicate based 45S5 glass. The printing parameters in Table 3.1 were
found to be compatible for a PCL/45S5 composite (Figure 3.9) as well. The average pore
size for all compositions was ~360 µm with a filament spacing of 800 µm (Figure 3.9A),
similar to the 13-93B3 composite (Figure 3.3A). A common feature of both the 13-93B3
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and the 45S5 composite is the filaments filling in the pore space rather than bridging
them. In both cases, the result is a mesh structure with pores only in the z-direction rather
than a true scaffold (Figure 3.3C and 3.9C). This indicated that the mesh structure was a
product of the printing process rather than the glass composition.

Figure 3.9 Micro- and macroscopic images of PCL/45S5 composite scaffolds.
(A) Optical microscopic image showing the pores (~160 µm) in a composite scaffold
fabricated with C5 paste. (B) Scaffolds fabricated with different composite pastes
(C1 to C5). (C) Cross section of C5 scaffold.

3.5. PRINTING STEM CELLS IN MATRIGEL
3.5.1. Matrigel Droplets. Initially, experiments were conducted to print droplets
of hASCs suspended in DMEM. It was determined that a 110 µm (32G) nozzle tip
extruded droplets less than 500 µm, which was suitable for printing either on top or
alongside the deposited PCL/glass filaments, allowing the printing of the Matrigel to not
interfere with the printing of the composite. However, DMEM droplets evaporated too
quickly, drying out the cells. Therefore, the option of using a hydrogel, Matrigel, as a
medium to suspend the hASCs was examined. The initial set of experiments included
dispensing the Matrigel droplets without cells with the syringe dispensing system set-up
to determine an appropriate concentration of Matrigel in DMEM and droplet size. A
concentration of 10mg/mL Matrigel provided smaller drops (~100 µm), while 8 mg/mL
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Matrigel produced larger drops (~500 µm), and 4 mg/mL Matrigel produced even larger
drops (1 mm) (Figure 3.10).

Figure 3.10 Matrigel droplets with concentrations ranging from 4 mg/mL to 10 mg/mL.

In each case, Matrigel provided a stable environment for the cells without drying
(measured for up to 10 minutes) with longer times when printed closely together as
would be in a scaffold. As the filament width of the scaffolds was measured between 400
to 500 µm, a Matrigel concentration of 9 mg/mL was selected to be appropriate for
generating droplets which could be deposited on top of the filaments. Approximately
1x106 cells suspended in PBS were pipetted in Matrigel. Immediately before printing, the
hASCs+Matrigel bio-ink was transferred to a 160 µm nozzle tip that had been kept on
ice.
The ideal parameters for dispensing hASCs+Matrigel bio-ink droplets were
investigated. Parameters including distance of the nozzle tip from glass slide, dispensing
time of droplet, and air pressure were varied (Table 3.2).
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Table 3.2 Experimental set-up to determine hASC + Matrigel printing parameters.
Distance from Dispensing Time Air Pressure
Substrate (μm)
(ms)
(psi)
100
25
10
200
25
10
100
35
10
200
35
10
100
25
20
200
25
20
100
35
20
200
35
20

Droplets made at higher air pressure (20 psi) only showed the presence of cells in
a blue ring (Figure 3.11E-H) indicating that cells are at the boundary of the droplet due to
the high pressure irrespective of the other two parameters. Droplets printed at the lower
air pressure (10 psi) provide a more uniform distribution of cells, the presence of which
are indicated with white arrows (Figure 3.11A-D). An even distribution of cells is ideal
when printing to ensure better coverage of the scaffold.
Droplets printed with 10 psi and a height of 200 µm from the substrate had more
cells (152±1) in comparison to those printed at 10 psi with a height of 100 µm (127±20).
When comparing the pulse time, the droplets printed using 35 ms had a slightly higher
cell count than those printed using 25 ms by 3 cells on average. Therefore, the printing
parameters for Matrigel droplets were determined to be: (i) air pressure of 10 psi, (ii)
distance from glass slide of 200 µm, and (iii) pulse duration of 35 ms. These parameters
were used for all subsequent tests with Matrigel droplets.
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Figure 3.11 DAPI stained fluorescent images of 1x106 hASCs/mL Matrigel
printed at (A-D) 10 psi and (E-H) 20 psi. (A,E) A pulse time of 35 ms and 200 µm
distance from glass slide (B,F) 25 ms and 200 µm (C,G) 35 m s and 100 µm (D,H) 25 ms
and 100 µm. The average number of cells at 10 psi is 127 while the average number at 20
psi is 152. The cells are at the boundary of the droplet for 20 psi because of higher air
pressure.
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3.5.2. Viability of Stem Cells Printed on Composite Scaffold. The viability
of hASCs printed at 10 psi on three layers of the C5 composite was studied by
performing a live/dead assay after incubating the samples for 24 hours and 1 week. This
was to address the safety issue of using CF while depositing hASCS. The viability of
cells after 24 hours was 70±10% (Figure 3.12A and 3.12B) as calculated from 15
representative images of 3 scaffolds. After 1 week, the viability of cells was 58±11%
(Figure 3.12C and 3.12D). The cells and the Matrigel appear to be adhering to the
scaffold and spreading over the pores after 24 hours (Figure 3.12A).

Figure 3.12 Representative Live/Dead images of Matrigel encapsulated ASCs on C5
scaffold. Imaged after (A-B) 24 hours with 70% viability, and (C-D) 1 week with 58%
viability. Scale bars - 250 µm.

3.5.3. Matrigel Droplets in Multiple Layer Scaffolds. After printing three
layers of the PCL/13-93B3 composite (240 μm thick) with a single layer of Matrigel
droplets, the efficacy of this methods with multiple layer scaffolds was investigated.
Therefore, 10 layer PCL/13-93B3 scaffolds (800 μm thick) were printed without any
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Matrigel and compared to scaffolds with 5 layers of Matrigel droplets printed every two
layers (Figure 3.13). The scaffolds could not be printed any thicker due to material build
up on the edges causing bridging of the pores. Additionally, some of the scaffolds (about
1 in 4) demonstrated visible warping due to shrinkage stresses (Figure 3.13D).

Figure 3.13 C3 scaffolds printed (A) without and (B-C) with Matrigel.
(D) Side view of (C) showing warping. Scaffolds are 10x10 mm2 and 10 layers (800 μm
thick). The scaffold in (A) contains no Matrigel while the scaffolds in (B-C) contain 5
layers of Matrigel droplets printed every two layers.

Because the droplets affected the printing of the scaffold, it was decided that
further tests would use hydrogel filaments printed between the composite filaments rather
than hydrogel droplets (Figure 3.14). The placement of the droplets was not precise
enough using the current printer to avoid impeding deposition of the following composite
layers over time. In addition, printing hydrogel filaments between the composite
filaments could help when trying to fabricate pores in the x and y-direction.
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Figure 3.14 Comparison of two printing methods (A) with hydrogel droplets and (B) with
hydrogel filaments.

3.6. COMPARE PCL/13-93B3 COMPOSITE TO OTHER BIO-INKS
3.6.1. Without Cells. Single layers were printed for each bio-ink. Parameters
for the C3 composite filaments were determined in the previous section. PBS, used as a
control to measure cell death through the printing process, had a large amount of
spreading when printed even with a 60 µm nozzle and only 2 psi (Figure 3.15A).
Increasing the printing speed from 10 mm/s did not produce more consistent filament size
and shape. Pluronic (15% w/v) and Matrigel filaments (4.5 mg/mL) had similar
properties. Both required a 160 µm nozzle and were printed at 2 psi and 10 mm/s (Figure
3.15B and 3.15C). Any larger nozzle or higher pressure and the hydrogel spread such that
there was no longer space between the printed filaments and instead there was just a
puddle. A smaller nozzle (<160 μm) and decreased pressure (<2 psi) did not print
consistently and produced filaments that were not continuous. A filament spacing of 1
mm was required for the PBS, Matrigel, and Pluronic to prevent the filaments
overlapping while the composite could be printed with 800 μm spacing.
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Figure 3.15 Macroscopic images of (A) PBS, (B) Matrigel, (C) Pluronic, and (D) C3
Composite. Images were taken within 5 minutes of printing.

3.6.2. With Cells. Approximately 5x106 rBMSCs/mL were suspended in C3
paste, Matrigel, Pluronic, and PBS. One layer was printed of each bio-ink and they were
incubated in cell culture conditions for 1 day and 1 week. The majority of the rBMSCs in
the pluronic and Matrigel are noticeably suspended after one day while after 1 week there
is a mix of suspended rBMSCs and adhered rBMSCs exhibiting a fibroblast-like
morphology integral to MSCs (Figure 3.16B and 3.16C). Using bright field microscopy,
no cells can be observed in the composite as the filaments were too dense to image
through properly (Figure 3.16D).
Upon examination using a Live/Dead stain and fluorescent microscopy, the
composite shows signs of cell survival within the filament both one day and one week
after printing with rBMSCs (Figure 3.17). With Matrigel and Pluronic, the cells are
mostly in clusters and remain in the filaments in which they were printed after one day
Figure 3.17B and 3.17C). After a week, the cells in Matrigel and Pluronic started to
spread and adhere to the plate, though some remained suspended (Figure 3.17F and
3.17G). The rBMSCs printed with the PBS show an increased amount of death along the
edges of where they were printed both one day and one week after printing (Figure 3.17A
and 3.17E). There was no statistical difference between the viability of the cells of each
bio-ink both one day and one week after printing indicating no long term negative effects
after printing (Figure 3.17I and 3.17J).
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Figure 3.16 Bright field images of rBMSCs after (A,C,E,G) 1 day and (B,D,F,H) 1 week
suspended in (A-B) PBS, (C-D) Matrigel (4.5 mg/mL), (E-F) Pluronic (15% w/v), and
(G-H) C3 composite. The cells were printed at a concentration of 5x106 per mL. Scale
bars - 1 mm.
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Figure 3.17 Viability of rBMSCs (A-D,I) 1 day and (E-H,J) 1 week after printing
suspended in (A,E) PBS, (B,F) Matrigel, (C,G) Pluronic, and (D,H) the C3 composite.
No statistical difference in viability between the different bio-inks both (I) 1 day and (J) 1
week after printing. The rBMSCs were suspended at a concentration of 5x106 cells per
mL. Scale bars - 250 µm.

3.7. COMPARISON OF DIFFERENT STEM CELL POPULATIONS
3.7.1. Rat SVF. The concentration of cells per mL of bio-ink was investigated
using 25% w/v Pluronic with rSVF and rBMSCs. A single layer of Pluronic was printed
in a 10x10 mm2 scaffold. After one day, a live/dead stain shows ~95% cell death for the
rSVF at all concentrations (Figure 3.18A-C). It was also noticed that the Pluronic did not
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remain in distinct filaments after the media was added. Most likely, this was due to the
media being too cold when added, causing the Pluronic to dissolute. A high degree of cell
death is expected with SVF as it contains many different cell types and the culture media
(D-10) is specific just to MSCs. Therefore, the experiment was repeated with rBMSCs
with 5x106 and 10x106 cells. However, once again there was about 96% cell death after
one day (Figure 3.18D-E). The large amount of cell death after one day using both rSVF
and rBMSCs suggests that 25% w/v Pluronic is not ideal for cell survival.

Figure 3.18 Live/Dead images of cells suspended in 25% w/v Pluonic at
(A) 5x106, (B) 10x106, and (C) 20x106 rSVF per mL and (D) 5x106 and (E) 10x106
rBMSCs per mL. The images are the (i) live cells, (ii) dead cells, and (iii) a combined
image of live and dead cells. All show <5% viability. Scale bars - 250 µm.
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Despite the problems encountered using rSVF previously, the positive results
from different bio-inks using rBMSCs prompted a trial with rSVF. Approximately 5x106
rSVF/mL of bio-ink was suspended in PBS, Matrigel (4.5 mg/mL), Pluronic (15% w/v)
and the C3 composite. One layer of each bio-ink was printed and scaffolds were
incubated in cell culture conditions for one day. The results show a distinct lack of cells
via both bright field and fluorescent imaging (Figure 3.19). A large amount of cell death
is expected within the first 24 hours for SVF due to the variety of cell types and the
culture media being optimized for only MSCs. Therefore, it was concluded that a
live/dead analysis could not be performed after one day.

Figure 3.19 (A,C,E,G) Bright field and (B,D,F,H) live/dead images one day after printing
rSVF suspended in (A-B) PBS, (C-D) Matrigel (4.5 mg/mL), (E-F) Pluronic (15% w/v),
and (G-H) C3 composite. The cells were printed at a concentration of 5x106 per mL and
had <5% viability for all bio-inks. The images are the (i) live cells, (ii) dead cells, and
(iii) a combined image of live and dead cells. The scale bars on the bright field images
are 1 mm while the fluorescent images are 250 µm.
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3.7.2. Human Cells. A mixture of 5x106 hASCs and hBMSCs was suspended
in the different bio-inks, printed, and analyzed after one day using a live/dead stain and
bright field microscopy (Figure 3.20). Matrigel (4.5 mg/mL) and Pluronic (15% w/v)
both had a mixture of cells staying suspended in the hydrogel as well as cells showing a
fibroblast-like morphology (Figure 3.20B and 3.20C). The cells printed in Pluronic are
similar to the PBS control in that they started showing directional growth (Figure 3.20A
and 3.20C). The composite shows signs of cell survival within the filaments as well
(Figure 3.20D). Each bio-ink showed greater than 96% viability.

Figure 3.20 (A,C,E,G) Bright field and (B,D,F,H) live/dead images one day after printing
hASCs and hBMSCs suspended in (A,B) PBS, (C,D) Matrigel (4.5 mg/mL), (E,F)
Pluronic (15% w/v), and (G,H) C3 composite. The cells were printed at a concentration
of 5x106 per mL. The images are the (i) live cells, (ii) dead cells, and (iii) a combined
image of live and dead cells. The scale bars on the bright field images are 1 mm while the
fluorescent images are 250 µm.
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3.7.3. Viability. The viability of the different stem cell populations was
compared after one day for all bio-inks. A low viability was seen for all cell types and
concentrations in the 25% w/v Pluronic while there was low and inconsistent viability of
the rSVF in all bio-inks (Figure 3.21). For all bio-inks, the rBMSCs had an average
viability of 60% or higher while the hMSCs had an average viability of 80% or higher.
However, the only difference between the two statistically is with the 15% w/v Pluronic.
From this data, it was concluded that the 25% w/v Pluronic provided unsuitable tissue
culture conditions, the viability of rSVF cannot be evaluated after one day, and there is
no statistical difference in viability for PBS, Matrigel, 15% w/v Pluronic, and the
composite.

3.8. INVESTIGATING THE BEST METHOD TO ANALYZE STEM CELL
ACTIVITY AFTER PRINTING CELLS IN DIFFERENT BIO-INKS
After both one day and one week, it can be determined that CyQuant is not a viable
option to estimate cell number for the composite (Figure 3.22C-D). Approximately 4.57x104 cells were printed per scaffold and almost no cells were measured in the composite
after one day. After one day, the assay detected approximately 1/10 of the cells printed in
Matrigel and Pluronic and ~1/2 the cells printed in PBS. Matrigel showed a six-fold
increase in cell number after one week while the Pluronic has a ten-fold increase, which
indicates the cells are surviving and proliferating. Surprisingly, the MTT assay exhibited
a decrease in absorbance, which is equated with percent viability, after one week for all
bio-inks (Figure 3.22A and 3.22B). This is inconsistent with the results from the
live/dead analysis that show similar viability from one day to one week (Figure 3.17I and
3.22J). This could be due to problems when transferring to the 96-well plate but the MTT
assay does not seem to be a viable option as a high through put assay to analyze the
composite scaffolds. The composite scaffolds returned unusally high absorbance numbers
with a high standard deviation that suggest the composite itself interferes with the assay
(Figure 3.22A and 2.32B). The high standard deviations and odd decrease in absorbance
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after one week suggest that an additional trial would need to be run to make further
conclusions on the efficacy of using this method to analyze the other bio-inks.

Figure 3.21 Viability of different cell types in all bio-inks after one day.
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Figure 3.22 Methods to evaluate bio-printed rBMSCs, (A-B) Viability and (C-D) number
of rBMSCs (A,C) 1 day and (B,D) 1 week after printing. There was no significant
difference between the Matrigel and Pluronic. The results are inconsistent for the C3
composite and indicate the unsuitability of these particular tests when determining
viability and cell number. The cells were printed at a concentration of 5x106 cells per mL.
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4. CONCLUSION

Printing parameters for different glass concentrations of a chloroform-dissolved
PCL/13-93B3 glass composite were established using a modified extrusion printer.
Scaffolds with no warpage were fabricated using 30-50wt.% glass. Scaffolds exhibited
bioactivity through a controlled release of bioactive glass in media over two weeks and
the formation of hydroxyapatite-like crystals on the surface. This demonstrates that
bioactive glass can be printed without the need to heat up to hundreds of degrees
centigrade, making it possible to print cells concurrently on the scaffold.
The effect of chloroform evaporation on cell viability was determined by printing
droplets of hASCs suspended in Matrigel on a single layer of the composite paste. One
week after printing and incubating under standard cell culture conditions, more than 60%
hASCs were shown to be viable. With multi-layer scaffolds, the droplets could not be
precisely placed such that they did not interfere with printing the next layer of the
composite. This caused the scaffolds to print inconsistently and fill in the pores which
indicates that although cells can survive the printing and choice of biomaterials, they
need to be printed with a different method in order to maintain the integrity of the
scaffold.
The ability of cells to be printed in different bio-inks as filaments and not droplets
was evaluated. MSCs were suspended in the composite, Matrigel, and Pluronic hydrogel
then printed in a single layer and incubated under standard cell culture conditions for one
day and one week. Matrigel and Pluronic had a mix of rBMSCs both suspended and
exhibiting spreading behavior after one week while PBS only had spreading cells. The
viability of all the bio-inks after both one day and one week as measured using a
live/dead assay was over 60%. There was no significant difference between the viability
of the different bio-inks, which means using the composite as a bio-ink is feasible
Different sources of MSCs were printed to evaluate the ideal cell type for
bioprinting. One day after printing, a mixture of hASCs and hBMSCs had a viability of
over 96% in all bio-inks. The cells suspended in PBS and Pluronic even showed
directional growth typical of spreading MSCs while the cells suspended in Matrigel
showed fibroblast-like morphology. This is in comparison to rBMSCs which had over
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60% viability and fibroblast-like morphology in PBS, Pluronic, and Matrigel. rSVF was
investigated as a possible source; however, evaluation should not be performed after one
day.
In order to determine the best method to measure cellular activity after printing,
different biological assays were evaluated. The composite, Matrigel, and Pluronic were
evaluated at 1 day and 1 week after printing using a MTT assay, CyQuant assay, and a
Live/Dead stain. The MTT and CyQuant assays were unable to accurately detect cells
within the composite leaving the Live/Dead stain as the best method to evaluate cell
numbers and viability.
Future directions include evaluating different MSC populations on a multiple
layer scaffold for both viability and differentiation capacity. Another direction would be
investigating the use of different polymers and solvents and their uses for applications
besides bone.
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